. 2016 Oct 25;41(3):287–296. doi: 10.5114/ceji.2016.63129
Copyright: © 2016 Polish Society of Experimental and Clinical Immunology
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Fig. 9.
Impact of GvHD prophylaxis on EBV reactivation